Two-Week Prophylaxis May Prevent Hep C After Kidney Transplant

Loading

— Direct-acting antiviral prophylaxis worked in all 10 cases in pilot trial

By Kristen Monaco

Short-term prophylaxis with direct-acting antivirals was fully effective at protecting kidney transplant recipients when their donors had hepatitis C, a proof-of-concept study showed.

In the small, uncontrolled trial, a 2-week prophylactic course prevented hepatitis C infection in all 10 negative recipients of positive donor kidneys, Christine Durand, MD, of Johns Hopkins University School of Medicine in Baltimore, and colleagues, found. Read the article in MedPage Today.

Loading

Teen desperately needed a kidney, but her dad already had 3 transplants. Who could save her?

Loading

By Phaedra Threthan

This summer, the last thing on Kaitlin Seigel’s mind was whether she’d be able to enjoy a Thanksgiving meal with her family.

The 15-year-old from Clark, New Jersey, felt nauseous all the time. She was listless and all the color was gone from her face. She couldn’t eat, and the lack of nourishment was making her weak. She didn’t want to hang out with her friends or take part in any school activities, fearful she might get sick. The isolation made her sad and anxious.
Read the full story in USA Today.

Loading

Donors, Recipients, Practitioners All Face Barriers to Kidney Transplantation

Loading

By Kyle Munz

Presenters at ASN Kidney Week 2023 emphasized the importance of patient education, awareness, and advocacy in the realm of kidney transplantation.

A session at ASN Kidney Week 2023 offered first-perspectives from patients and professionals on the growing efforts to mitigate barriers and inequities impacting patients in need of kidney transplants. Presentations featured stories from a kidney transplant recipient and donor, as well as evidence-based knowledge highlighting the needs to increase donor numbers and patient engagement. Read the full article in AJMC.

Loading

Researchers chart new approach to improving kidney transplant access

Loading

by Prabhjot Sohal

According to nephrologist Dr. Amit Garg, for those with advanced chronic kidney disease, the treatment options are stark: continuous dialysis or a kidney transplant to survive.

“A kidney transplant not only gives a patient up to a decade of longer life and quality of life, but data also shows that every 100 kidney transplant procedures save the health care system a staggering $20 million over five years by sidelining dialysis costs. Read the full article in Medical Xpress.

Loading

Could kidney transplant patients be spared a lifetime of immunosuppressants?

Loading


By Annalisa Merelli

Kidney transplants are the most common organ transplant procedure in the U.S., with 25,000 taking place in 2022. But for patients who receive new kidneys, the transplant is often followed by severe lifelong challenges, many of which are linked to the immunosuppression drug regimen required after surgery to ensure the body does not reject the new organ. These treatments have side effects and toxicities that impact patients’ long-term health, and even survival, leading to a transplant failure rate of 30-50% at the 10-year mark. Read the full article in STAT.

Loading

Couples exchange kidneys: Miami Transplant Institute performs 2-way paired exchange

Loading

By Niko Clemons

Two lives were saved at once after a paired kidney exchange at the Miami Transplant Institute.

Doctors diagnosed Michael Deitado with chronic kidney disease when he was 28 years old. Fast forward 29 years, he was in desperate need of a kidney transplant. His wife, Astrid, was a perfect kidney donor match, but her kidneys were too small. Check out the full story from 6 (NBC) South Florida News.

Loading